Concepts (304)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amniotic Fluid | 6 | 2025 | 147 | 2.520 |
Why?
|
| Biocompatible Materials | 4 | 2026 | 108 | 2.310 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 7 | 2025 | 83 | 2.220 |
Why?
|
| Ovarian Neoplasms | 5 | 2025 | 420 | 2.180 |
Why?
|
| Tissue Scaffolds | 6 | 2025 | 83 | 2.110 |
Why?
|
| Extracellular Vesicles | 2 | 2026 | 76 | 1.750 |
Why?
|
| Macrophages | 9 | 2026 | 667 | 1.720 |
Why?
|
| Amnion | 10 | 2016 | 42 | 1.530 |
Why?
|
| Umbilical Cord | 3 | 2025 | 56 | 1.510 |
Why?
|
| Collagen | 3 | 2025 | 273 | 1.400 |
Why?
|
| Tumor Microenvironment | 3 | 2025 | 713 | 1.260 |
Why?
|
| Wound Healing | 5 | 2026 | 490 | 1.140 |
Why?
|
| Immunomodulation | 2 | 2026 | 84 | 1.100 |
Why?
|
| Nanotechnology | 2 | 2019 | 50 | 1.030 |
Why?
|
| Chondroitin Sulfates | 2 | 2017 | 14 | 1.010 |
Why?
|
| Cell Communication | 2 | 2025 | 188 | 1.010 |
Why?
|
| Tissue Engineering | 3 | 2017 | 152 | 0.970 |
Why?
|
| Transcriptome | 4 | 2026 | 1103 | 0.970 |
Why?
|
| Immunotherapy | 4 | 2026 | 768 | 0.970 |
Why?
|
| Sugars | 1 | 2026 | 17 | 0.950 |
Why?
|
| Spheroids, Cellular | 1 | 2025 | 59 | 0.910 |
Why?
|
| Foreign-Body Reaction | 1 | 2025 | 16 | 0.890 |
Why?
|
| Biomimetic Materials | 4 | 2021 | 9 | 0.880 |
Why?
|
| Prostheses and Implants | 2 | 2025 | 146 | 0.820 |
Why?
|
| Bone Marrow Cells | 4 | 2015 | 243 | 0.800 |
Why?
|
| Regeneration | 2 | 2017 | 230 | 0.800 |
Why?
|
| Exosomes | 4 | 2025 | 60 | 0.790 |
Why?
|
| Horses | 10 | 2016 | 94 | 0.770 |
Why?
|
| Animals | 43 | 2026 | 33912 | 0.770 |
Why?
|
| Immunity, Innate | 1 | 2025 | 406 | 0.740 |
Why?
|
| Primary Cell Culture | 2 | 2025 | 106 | 0.730 |
Why?
|
| Inflammation | 4 | 2026 | 1489 | 0.730 |
Why?
|
| Premature Birth | 1 | 2026 | 428 | 0.690 |
Why?
|
| Amphibians | 1 | 2021 | 3 | 0.680 |
Why?
|
| Cell Differentiation | 15 | 2024 | 1928 | 0.670 |
Why?
|
| Down Syndrome | 1 | 2023 | 233 | 0.640 |
Why?
|
| Polyglycolic Acid | 3 | 2016 | 24 | 0.640 |
Why?
|
| Regenerative Medicine | 2 | 2021 | 39 | 0.620 |
Why?
|
| Lactic Acid | 3 | 2016 | 149 | 0.600 |
Why?
|
| Tumor Escape | 1 | 2019 | 65 | 0.600 |
Why?
|
| Cells, Cultured | 15 | 2017 | 2885 | 0.580 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2019 | 127 | 0.550 |
Why?
|
| Nanoparticles | 4 | 2026 | 310 | 0.550 |
Why?
|
| Cancer Vaccines | 1 | 2019 | 191 | 0.550 |
Why?
|
| Cell Culture Techniques | 5 | 2016 | 274 | 0.510 |
Why?
|
| Osteoblasts | 2 | 2015 | 175 | 0.510 |
Why?
|
| Chondrogenesis | 2 | 2016 | 31 | 0.490 |
Why?
|
| Hyaluronic Acid | 1 | 2017 | 107 | 0.490 |
Why?
|
| Chondrocytes | 1 | 2016 | 48 | 0.470 |
Why?
|
| Drug Carriers | 2 | 2026 | 124 | 0.460 |
Why?
|
| Culture Media, Conditioned | 2 | 2016 | 81 | 0.460 |
Why?
|
| Pregnancy | 7 | 2026 | 7512 | 0.450 |
Why?
|
| Poloxamer | 1 | 2014 | 14 | 0.430 |
Why?
|
| Cell Separation | 3 | 2011 | 218 | 0.430 |
Why?
|
| Chitosan | 1 | 2014 | 27 | 0.420 |
Why?
|
| Bupivacaine | 1 | 2014 | 28 | 0.420 |
Why?
|
| Environment | 1 | 2015 | 149 | 0.410 |
Why?
|
| Chorionic Villi | 2 | 2024 | 20 | 0.410 |
Why?
|
| Cell Lineage | 2 | 2015 | 349 | 0.410 |
Why?
|
| Cell Movement | 1 | 2017 | 876 | 0.400 |
Why?
|
| Anesthetics, Local | 1 | 2014 | 83 | 0.400 |
Why?
|
| Cytokines | 5 | 2025 | 1339 | 0.400 |
Why?
|
| Diethylhexyl Phthalate | 1 | 2013 | 6 | 0.400 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 301 | 0.400 |
Why?
|
| Platelet-Rich Plasma | 3 | 2020 | 21 | 0.390 |
Why?
|
| Antineoplastic Agents | 3 | 2019 | 1826 | 0.390 |
Why?
|
| Cell Proliferation | 12 | 2019 | 2465 | 0.390 |
Why?
|
| Female | 24 | 2026 | 70963 | 0.380 |
Why?
|
| Bone and Bones | 1 | 2015 | 308 | 0.370 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2012 | 27 | 0.370 |
Why?
|
| Mice | 8 | 2026 | 18301 | 0.360 |
Why?
|
| Spermatogenesis | 1 | 2013 | 166 | 0.360 |
Why?
|
| Liposomes | 1 | 2012 | 201 | 0.340 |
Why?
|
| Inflammation Mediators | 4 | 2016 | 226 | 0.340 |
Why?
|
| Stem Cells | 4 | 2023 | 702 | 0.340 |
Why?
|
| Embryonic Stem Cells | 1 | 2012 | 157 | 0.340 |
Why?
|
| Cell Size | 1 | 2011 | 77 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 3 | 2026 | 4738 | 0.330 |
Why?
|
| Uterus | 1 | 2014 | 541 | 0.320 |
Why?
|
| Rats, Inbred Lew | 4 | 2017 | 59 | 0.310 |
Why?
|
| Humans | 25 | 2026 | 131163 | 0.310 |
Why?
|
| Cell Line, Tumor | 5 | 2025 | 3748 | 0.300 |
Why?
|
| Mice, Inbred BALB C | 2 | 2025 | 978 | 0.300 |
Why?
|
| Gene Expression Profiling | 3 | 2026 | 1801 | 0.290 |
Why?
|
| Neoplasms | 2 | 2021 | 3016 | 0.290 |
Why?
|
| Biomimetics | 2 | 2021 | 17 | 0.280 |
Why?
|
| Endometrium | 3 | 2016 | 292 | 0.280 |
Why?
|
| Flow Cytometry | 5 | 2015 | 765 | 0.270 |
Why?
|
| Lipopolysaccharides | 3 | 2026 | 299 | 0.270 |
Why?
|
| Kinetics | 3 | 2019 | 1088 | 0.250 |
Why?
|
| Delayed-Action Preparations | 3 | 2016 | 123 | 0.250 |
Why?
|
| Rats | 6 | 2020 | 3370 | 0.250 |
Why?
|
| Cell-Derived Microparticles | 2 | 2016 | 26 | 0.240 |
Why?
|
| Nanomedicine | 1 | 2026 | 33 | 0.240 |
Why?
|
| Monocytes | 2 | 2025 | 335 | 0.230 |
Why?
|
| Tendons | 4 | 2016 | 33 | 0.230 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2025 | 254 | 0.230 |
Why?
|
| Mannose | 1 | 2025 | 25 | 0.230 |
Why?
|
| Cross-Linking Reagents | 1 | 2025 | 47 | 0.220 |
Why?
|
| Extracellular Matrix | 1 | 2026 | 232 | 0.220 |
Why?
|
| Adaptive Immunity | 1 | 2025 | 101 | 0.210 |
Why?
|
| Interferon-gamma | 1 | 2026 | 544 | 0.200 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2026 | 639 | 0.200 |
Why?
|
| Chromosomes | 1 | 2023 | 120 | 0.190 |
Why?
|
| Particle Size | 2 | 2014 | 135 | 0.190 |
Why?
|
| RNA, Messenger | 3 | 2026 | 2550 | 0.190 |
Why?
|
| Breast Neoplasms | 3 | 2021 | 2602 | 0.180 |
Why?
|
| Epithelial Cells | 4 | 2015 | 905 | 0.180 |
Why?
|
| Proteomics | 1 | 2026 | 615 | 0.180 |
Why?
|
| Beclin-1 | 1 | 2021 | 33 | 0.180 |
Why?
|
| Pilot Projects | 1 | 2026 | 1445 | 0.170 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2021 | 34 | 0.170 |
Why?
|
| Spermatozoa | 2 | 2016 | 254 | 0.170 |
Why?
|
| Neural Tube Defects | 1 | 2024 | 330 | 0.170 |
Why?
|
| Sirtuin 1 | 1 | 2021 | 55 | 0.170 |
Why?
|
| Cell Shape | 3 | 2016 | 67 | 0.170 |
Why?
|
| MicroRNAs | 2 | 2026 | 889 | 0.170 |
Why?
|
| Ascites | 1 | 2021 | 99 | 0.170 |
Why?
|
| Biology | 1 | 2021 | 24 | 0.170 |
Why?
|
| Gene Expression Regulation | 4 | 2016 | 2323 | 0.160 |
Why?
|
| Homeodomain Proteins | 2 | 2021 | 555 | 0.160 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2019 | 16 | 0.160 |
Why?
|
| Hyaluronan Receptors | 2 | 2017 | 64 | 0.150 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 4697 | 0.150 |
Why?
|
| Mammals | 1 | 2021 | 253 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2021 | 197 | 0.150 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 79 | 0.150 |
Why?
|
| Osteogenesis | 4 | 2015 | 182 | 0.150 |
Why?
|
| Embryo, Mammalian | 1 | 2021 | 403 | 0.150 |
Why?
|
| Cell Survival | 3 | 2016 | 826 | 0.140 |
Why?
|
| Cattle | 3 | 2016 | 501 | 0.140 |
Why?
|
| Stem Cell Niche | 2 | 2016 | 55 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2021 | 1205 | 0.140 |
Why?
|
| RNA | 2 | 2013 | 517 | 0.140 |
Why?
|
| Hydrogels | 2 | 2020 | 92 | 0.140 |
Why?
|
| Antigens, Differentiation | 2 | 2016 | 63 | 0.140 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2016 | 354 | 0.130 |
Why?
|
| Immunologic Factors | 1 | 2019 | 190 | 0.130 |
Why?
|
| Adenoma | 1 | 2019 | 144 | 0.130 |
Why?
|
| Cell- and Tissue-Based Therapy | 2 | 2015 | 151 | 0.130 |
Why?
|
| Dendritic Cells | 1 | 2019 | 439 | 0.120 |
Why?
|
| Endometritis | 1 | 2016 | 9 | 0.120 |
Why?
|
| DNA | 2 | 2013 | 1399 | 0.120 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 821 | 0.120 |
Why?
|
| Tenocytes | 1 | 2016 | 4 | 0.120 |
Why?
|
| Genetic Vectors | 1 | 2019 | 892 | 0.120 |
Why?
|
| Receptors, Leptin | 1 | 2016 | 40 | 0.120 |
Why?
|
| RNAi Therapeutics | 1 | 2016 | 17 | 0.120 |
Why?
|
| Sperm Head | 2 | 2013 | 9 | 0.120 |
Why?
|
| Microspheres | 1 | 2016 | 66 | 0.120 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2016 | 68 | 0.120 |
Why?
|
| Interleukin-4 | 1 | 2016 | 144 | 0.120 |
Why?
|
| Hernia, Ventral | 1 | 2015 | 35 | 0.110 |
Why?
|
| Immunohistochemistry | 3 | 2021 | 1591 | 0.110 |
Why?
|
| Surgical Mesh | 1 | 2015 | 63 | 0.110 |
Why?
|
| Herniorrhaphy | 1 | 2015 | 71 | 0.110 |
Why?
|
| Cell Adhesion | 1 | 2016 | 308 | 0.110 |
Why?
|
| Granulosa Cells | 1 | 2016 | 143 | 0.110 |
Why?
|
| Bone Regeneration | 1 | 2015 | 33 | 0.110 |
Why?
|
| Technology, Pharmaceutical | 1 | 2014 | 19 | 0.110 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2014 | 49 | 0.110 |
Why?
|
| Leptin | 1 | 2016 | 218 | 0.110 |
Why?
|
| Fertilization in Vitro | 1 | 2016 | 155 | 0.110 |
Why?
|
| Solubility | 1 | 2014 | 117 | 0.110 |
Why?
|
| Breast | 1 | 2016 | 215 | 0.100 |
Why?
|
| Signal Transduction | 2 | 2025 | 4686 | 0.100 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 664 | 0.100 |
Why?
|
| Ethinyl Estradiol | 1 | 2013 | 11 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2014 | 437 | 0.100 |
Why?
|
| DNA Fragmentation | 1 | 2013 | 53 | 0.100 |
Why?
|
| Phagocytosis | 1 | 2014 | 190 | 0.100 |
Why?
|
| Carboxylesterase | 1 | 2013 | 6 | 0.100 |
Why?
|
| Aphids | 1 | 2013 | 6 | 0.100 |
Why?
|
| Ligaments | 1 | 2013 | 20 | 0.100 |
Why?
|
| Crops, Agricultural | 1 | 2013 | 13 | 0.100 |
Why?
|
| Tendon Injuries | 1 | 2013 | 15 | 0.100 |
Why?
|
| Insecticide Resistance | 1 | 2013 | 30 | 0.100 |
Why?
|
| Antigens, CD | 1 | 2015 | 410 | 0.100 |
Why?
|
| Insect Proteins | 1 | 2013 | 95 | 0.090 |
Why?
|
| Avidin | 1 | 2012 | 12 | 0.090 |
Why?
|
| Lewis X Antigen | 1 | 2012 | 11 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 1 | 2019 | 740 | 0.090 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2012 | 24 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 121 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 1105 | 0.090 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2012 | 115 | 0.090 |
Why?
|
| Paracrine Communication | 1 | 2012 | 69 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2021 | 2406 | 0.090 |
Why?
|
| Reproduction | 1 | 2013 | 210 | 0.090 |
Why?
|
| Fluorescent Dyes | 2 | 2013 | 246 | 0.090 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 1280 | 0.090 |
Why?
|
| Fetal Stem Cells | 1 | 2011 | 5 | 0.090 |
Why?
|
| Translocation, Genetic | 1 | 2013 | 344 | 0.080 |
Why?
|
| Breeding | 1 | 2010 | 19 | 0.080 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 1129 | 0.080 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 62 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 288 | 0.080 |
Why?
|
| Zebrafish | 1 | 2013 | 418 | 0.080 |
Why?
|
| Phenotype | 2 | 2021 | 4497 | 0.080 |
Why?
|
| Time Factors | 2 | 2021 | 6196 | 0.080 |
Why?
|
| Adipogenesis | 1 | 2010 | 82 | 0.080 |
Why?
|
| Fetal Blood | 1 | 2011 | 176 | 0.080 |
Why?
|
| Cell Line | 1 | 2014 | 2552 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 1447 | 0.080 |
Why?
|
| Dogs | 1 | 2010 | 613 | 0.080 |
Why?
|
| Organoplatinum Compounds | 1 | 2008 | 34 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 2121 | 0.070 |
Why?
|
| Animals, Newborn | 1 | 2010 | 1021 | 0.060 |
Why?
|
| Chromatin | 1 | 2010 | 499 | 0.060 |
Why?
|
| Apoptosis | 3 | 2019 | 1827 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 981 | 0.060 |
Why?
|
| Transplantation, Homologous | 2 | 2020 | 670 | 0.060 |
Why?
|
| Adult | 1 | 2026 | 31282 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2026 | 224 | 0.060 |
Why?
|
| Hematologic Neoplasms | 1 | 2008 | 315 | 0.050 |
Why?
|
| Octamer Transcription Factor-3 | 2 | 2015 | 38 | 0.050 |
Why?
|
| Coculture Techniques | 2 | 2016 | 230 | 0.050 |
Why?
|
| Sperm Motility | 2 | 2016 | 113 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 526 | 0.040 |
Why?
|
| Italy | 2 | 2013 | 109 | 0.040 |
Why?
|
| Staining and Labeling | 2 | 2013 | 166 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2021 | 136 | 0.040 |
Why?
|
| Methylation | 1 | 2021 | 199 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2021 | 387 | 0.040 |
Why?
|
| Male | 6 | 2020 | 64957 | 0.040 |
Why?
|
| Printing, Three-Dimensional | 1 | 2020 | 88 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2021 | 362 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 400 | 0.040 |
Why?
|
| Fibrosis | 1 | 2021 | 429 | 0.040 |
Why?
|
| Integrative Medicine | 1 | 2019 | 15 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2019 | 209 | 0.030 |
Why?
|
| Autophagy | 1 | 2021 | 417 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2019 | 245 | 0.030 |
Why?
|
| Collagenases | 1 | 2016 | 15 | 0.030 |
Why?
|
| Follicular Fluid | 1 | 2016 | 6 | 0.030 |
Why?
|
| Sperm-Ovum Interactions | 1 | 2016 | 22 | 0.030 |
Why?
|
| Acrosome Reaction | 1 | 2016 | 11 | 0.030 |
Why?
|
| Sperm Capacitation | 1 | 2016 | 20 | 0.030 |
Why?
|
| Methacrylates | 1 | 2016 | 15 | 0.030 |
Why?
|
| Adsorption | 1 | 2016 | 33 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2020 | 663 | 0.030 |
Why?
|
| Cations | 1 | 2016 | 38 | 0.030 |
Why?
|
| Silicon Dioxide | 1 | 2016 | 27 | 0.030 |
Why?
|
| Acellular Dermis | 1 | 2015 | 7 | 0.030 |
Why?
|
| Arginase | 1 | 2016 | 34 | 0.030 |
Why?
|
| Tissue Adhesions | 1 | 2015 | 26 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2015 | 85 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2015 | 93 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2016 | 70 | 0.030 |
Why?
|
| Oligonucleotides | 1 | 2015 | 94 | 0.030 |
Why?
|
| Bone Substitutes | 1 | 2015 | 10 | 0.030 |
Why?
|
| Endocytosis | 1 | 2016 | 121 | 0.030 |
Why?
|
| Polymers | 1 | 2016 | 103 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2015 | 79 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2016 | 126 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2016 | 341 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 1272 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2015 | 105 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2016 | 192 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 645 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2021 | 3359 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 700 | 0.030 |
Why?
|
| Rabbits | 1 | 2015 | 575 | 0.030 |
Why?
|
| Activated-Leukocyte Cell Adhesion Molecule | 1 | 2013 | 1 | 0.030 |
Why?
|
| Stage-Specific Embryonic Antigens | 1 | 2013 | 3 | 0.030 |
Why?
|
| Progesterone | 1 | 2016 | 439 | 0.030 |
Why?
|
| Ectoderm | 1 | 2013 | 33 | 0.030 |
Why?
|
| Models, Animal | 1 | 2015 | 450 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2013 | 97 | 0.020 |
Why?
|
| Cats | 1 | 2013 | 117 | 0.020 |
Why?
|
| Equipment Design | 1 | 2015 | 512 | 0.020 |
Why?
|
| Mesoderm | 1 | 2013 | 106 | 0.020 |
Why?
|
| Propidium | 1 | 2013 | 3 | 0.020 |
Why?
|
| Parthenogenesis | 1 | 2013 | 1 | 0.020 |
Why?
|
| Diploidy | 1 | 2013 | 40 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2013 | 78 | 0.020 |
Why?
|
| Decorin | 1 | 2012 | 7 | 0.020 |
Why?
|
| Tenascin | 1 | 2012 | 33 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2012 | 110 | 0.020 |
Why?
|
| Gene Expression | 1 | 2016 | 1481 | 0.020 |
Why?
|
| Swine | 1 | 2015 | 1186 | 0.020 |
Why?
|
| DNA Primers | 1 | 2013 | 599 | 0.020 |
Why?
|
| Prognosis | 1 | 2021 | 4886 | 0.020 |
Why?
|
| Rupture | 1 | 2011 | 33 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2011 | 64 | 0.020 |
Why?
|
| Multipotent Stem Cells | 1 | 2011 | 28 | 0.020 |
Why?
|
| Recurrence | 1 | 2015 | 1489 | 0.020 |
Why?
|
| Animals, Domestic | 1 | 2011 | 40 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 2026 | 0.020 |
Why?
|
| Biological Assay | 1 | 2011 | 105 | 0.020 |
Why?
|
| Sperm Tail | 1 | 2010 | 8 | 0.020 |
Why?
|
| Sheep | 1 | 2011 | 229 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 6797 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2011 | 227 | 0.020 |
Why?
|
| Base Sequence | 1 | 2013 | 2730 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3464 | 0.020 |
Why?
|
| DNA Damage | 1 | 2010 | 511 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2008 | 686 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2011 | 943 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2008 | 594 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2015 | 3147 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 17753 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 21025 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 28601 | 0.010 |
Why?
|